AC1-IN-1,99.81%

产品编号:Bellancom-145830| CAS NO:2762422-55-7| 分子式:C18H18FN5O2| 分子量:355.37

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-145830
4200.00 杭州 北京(现货)
Bellancom-145830
6700.00 杭州 北京(现货)
Bellancom-145830
12500.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

AC1-IN-1

产品介绍 AC1-IN-1 是一种有效的选择性 AC1 抑制剂,其 IC50 为 0.54 µM. AC1-IN-1 在炎症性疼痛小鼠模型中表现出适度的抗异常疼痛的作用。AC1-IN-1 具有 CNS 活性。
生物活性

AC1-IN-1 is a potent and selective Adenylyl cyclase type 1 (AC1) inhibitor with an IC50 of 0.54 µM. AC1-IN-1 displays modest antiallodynic effects in a mouse model of inflammatory pain. AC1-IN-1 has CNS activity.

体外研究

AC1-IN-1 (compound 38; HEK293 cells; 30 µM, 1 hours) shows nontoxic to this human cell line.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay

Cell Line: HEK293 cells
Concentration: 30 µM
Incubation Time: 1 hours
Result: Showed nontoxic to HEK293 cells.
体内研究
(In Vivo)

AC1-IN-1 (5.6 mg/kg; i.v.) displays modest, yet statistically significant, antiallodynic effects at 1 h post-treatment compared to the 0 min (allodynic) time point.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male and female C57BL/6N mice (complete Freund’s adjuvant inflammatory pain model)
Dosage: 5.6 mg/kg (dissolved in 10% DMSO/10% Cremaphor/80% saline)
Administration: Intravenous injection; 2 hours
Result: Displayed modest, yet statistically significant, antiallodynic effects.
体内研究

AC1-IN-1 (5.6 mg/kg; i.v.) displays modest, yet statistically significant, antiallodynic effects at 1 h post-treatment compared to the 0 min (allodynic) time point.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male and female C57BL/6N mice (complete Freund’s adjuvant inflammatory pain model)
Dosage: 5.6 mg/kg (dissolved in 10% DMSO/10% Cremaphor/80% saline)
Administration: Intravenous injection; 2 hours
Result: Displayed modest, yet statistically significant, antiallodynic effects.
体内研究

AC1-IN-1 (5.6 mg/kg; i.v.) displays modest, yet statistically significant, antiallodynic effects at 1 h post-treatment compared to the 0 min (allodynic) time point.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male and female C57BL/6N mice (complete Freund’s adjuvant inflammatory pain model)
Dosage: 5.6 mg/kg (dissolved in 10% DMSO/10% Cremaphor/80% saline)
Administration: Intravenous injection; 2 hours
Result: Displayed modest, yet statistically significant, antiallodynic effects.
性状Solid
溶解性数据
In Vitro: 

DMSO : 25 mg/mL (70.35 mM; ultrasonic and warming and heat to 60°C)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.8140 mL 14.0698 mL 28.1397 mL
5 mM 0.5628 mL 2.8140 mL 5.6279 mL
10 mM 0.2814 mL 1.4070 mL 2.8140 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服